Page last updated: 2024-08-26

carbidopa, levodopa drug combination and selegiline

carbidopa, levodopa drug combination has been researched along with selegiline in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19905 (29.41)18.7374
1990's11 (64.71)18.2507
2000's1 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lieberman, A1
Jacobs, MB; Varon, J1
Cedarbaum, JM; Green-Parsons, A; Toy, LH1
Hodges, LC; Rapp, CG1
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W1
Elizan, TS; Moros, D; Yahr, MD1
Birkmayer, W1
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ1
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW1
Brannan, T; Yahr, MD1
Bennett, KM; Castiello, U1
Ahlskog, JE2
Ruggieri, S; Silver, DE1
Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N1

Reviews

5 review(s) available for carbidopa, levodopa drug combination and selegiline

ArticleYear
An integrated approach to patient management in Parkinson's disease.
    Neurologic clinics, 1992, Volume: 10, Issue:2

    Topics: Activities of Daily Living; Antiparkinson Agents; Carbidopa; Dopamine Agents; Drug Combinations; Humans; Levodopa; Parkinson Disease; Selegiline

1992
Treatment of Parkinson's disease. From theory to practice.
    Postgraduate medicine, 1994, Volume: 95, Issue:5

    Topics: Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Dopamine; Drug Combinations; Free Radicals; Humans; Levodopa; Oxygen; Parkinson Disease; Selegiline

1994
Initiating therapy for Parkinson's disease.
    Neurology, 1998, Volume: 50, Issue:6 Suppl 6

    Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Carbidopa; Cholinergic Antagonists; Delayed-Action Preparations; Dopamine Agonists; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Selegiline

1998
Medical treatment of later-stage motor problems of Parkinson disease.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: Amantadine; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Cholinergic Antagonists; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Humans; Levodopa; Nitriles; Nitrophenols; Parkinson Disease, Secondary; Propranolol; Randomized Controlled Trials as Topic; Selegiline; Tolcapone

1999
[Serotonin syndrome: report of a fatal case and review of the literature].
    Revista clinica espanola, 2002, Volume: 202, Issue:4

    Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome

2002

Trials

4 trial(s) available for carbidopa, levodopa drug combination and selegiline

ArticleYear
L-deprenyl (selegiline) added to Sinemet CR in the management of Parkinson's disease patients with motor response fluctuations.
    Clinical neuropharmacology, 1991, Volume: 14, Issue:3

    Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Movement; Parkinson Disease; Selegiline; Time Factors

1991
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
    Neurology, 1989, Volume: 39, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline

1989
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
    Annals of neurology, 1995, Volume: 38, Issue:5

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome

1995
Comparative study of selegiline plus L-dopa-carbidopa versus L-dopa-carbidopa alone in the treatment of Parkinson's disease.
    Annals of neurology, 1995, Volume: 37, Issue:1

    Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline; Treatment Outcome

1995

Other Studies

8 other study(ies) available for carbidopa, levodopa drug combination and selegiline

ArticleYear
Treating the progressive stages of Parkinson's disease.
    Postgraduate medicine, 1991, Volume: 90, Issue:1

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline

1991
New drugs for Parkinson's disease.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1990, Volume: 22, Issue:4

    Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Quality of Life; Selegiline

1990
Selegiline in the treatment of Parkinson's disease--long term experience.
    Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126

    Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Phenethylamines; Selegiline

1989
[Therapeutic strategies and tactics in parkinsonism].
    Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16

    Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders

1986
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline

1988
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
    Neurology, 1982, Volume: 32, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine

1982
Parkinson's disease: reorganization of the reach to grasp movement in response to perturbation of the distal motor patterning.
    Neuropsychologia, 1994, Volume: 32, Issue:11

    Topics: Aged; Antiparkinson Agents; Attention; Carbidopa; Drug Combinations; Female; Hand Strength; Humans; Kinesthesis; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline; Size Perception

1994
Drugs for Parkinson's disease.
    The Medical letter on drugs and therapeutics, 1993, Apr-16, Volume: 35, Issue:894

    Topics: Carbidopa; Dopamine Agents; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline

1993